State of Alaska, Department of Revenue - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 230 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
State of Alaska, Department of Revenue ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,530
+15.6%
56,186
-5.5%
0.02%
+18.8%
Q2 2023$1,323
-6.9%
59,484
-9.3%
0.02%
-5.9%
Q1 2023$1,421
+5.1%
65,608
-1.5%
0.02%0.0%
Q4 2022$1,352
-99.9%
66,614
+0.9%
0.02%
-26.1%
Q3 2022$1,692,000
-1.5%
65,995
-8.7%
0.02%
+9.5%
Q2 2022$1,718,000
+14.8%
72,284
+8.7%
0.02%
+31.2%
Q1 2022$1,497,000
+12.6%
66,509
-1.0%
0.02%
+23.1%
Q4 2021$1,330,000
-11.2%
67,199
-11.7%
0.01%
-13.3%
Q3 2021$1,497,000
-6.3%
76,109
+4.8%
0.02%
-6.2%
Q2 2021$1,598,000
-6.0%
72,641
+1.6%
0.02%
-11.1%
Q1 2021$1,700,000
-20.1%
71,471
-12.2%
0.02%
-25.0%
Q4 2020$2,128,000
+25.7%
81,381
-16.4%
0.02%
+14.3%
Q3 2020$1,693,000
+3.5%
97,306
+0.0%
0.02%0.0%
Q2 2020$1,636,000
+50.9%
97,296
+6.7%
0.02%
+23.5%
Q1 2020$1,084,000
+15.4%
91,206
+17.4%
0.02%
+41.7%
Q4 2019$939,000
-15.5%
77,666
-1.2%
0.01%
-20.0%
Q3 2019$1,111,000
+180.6%
78,604
+120.9%
0.02%
+114.3%
Q2 2019$396,000
-4.1%
35,580
+1.1%
0.01%0.0%
Q1 2019$413,000
-11.9%
35,187
+0.1%
0.01%
-22.2%
Q4 2018$469,000
-2.1%
35,137
+2.8%
0.01%
+12.5%
Q3 2018$479,000
-2.4%
34,194
+9.4%
0.01%
-11.1%
Q2 2018$491,000
-3.0%
31,270
+1.7%
0.01%
-18.2%
Q1 2018$506,000
+58.1%
30,760
+73.4%
0.01%
+37.5%
Q4 2017$320,00017,7400.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders